Delivery Order SPE2DB20D3103-SPE2DB25FN5N0

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx Unoready 300 mg pen injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,837.91 firm fixed price contract was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $15,459.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Cosentyx Unoready 300 mg pen, a specialty medication. The contract has a firm fixed price and an ultimate completion date of November 6, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the supply of Cosentyx Unoready 300 mg pen (2 ml) to the DLA Troop Support Medical program, which supports the Department of Defense. The contract has a ceiling value of $9,131.70 and a period of performance through April 30, 2024....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $9,447.36 for the delivery of a specialty medication, Cosentyx unoready 300 mg pen 2 ml. The contract has a period of performance through December 12, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,521.95, is for the delivery of the pharmaceutical product Cosentyx Unoready 300 mg Pen 2 ml. This is a firm-fixed price delivery order contract with a completion date of May 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $18,055.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx Unoready 300 mg Pen 2 ml, a specialty medication, with an ultimate completion date of October 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Cosentyx Unoready 300 mg pens, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $6,087.80, has a period of performance through September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 syringes. The $4,767.17 firm fixed-price contract has a completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,407.58 firm fixed-price delivery order contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,522.92, is a delivery order for the pharmaceutical product Cosentyx Unoready 300 mg Pen 2 ml. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed price contract. AmerisourceBergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, PA....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN5N0
    Delivery Order

This federal contract award, valued at $12,806.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx Unoready 300 mg pen 2 ml. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 24, 2025.

AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/23/25, 10:00 AM